Order results by:
| Issue | Title | |
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... .043); platelet distribution width (β=1.36, 95% CI: 0.22-2.51; p=0.02); creatinine (β=0.11, 95% CI: 0.011-0.21; p ..." | ||
| Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
| A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
| "... platelet aggregative reactivity (RPAR). Material and methods. Patients (n=40) with ischemic heart disease ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... . Antiplatelet efficacy of ASA medicines were estimated by effects on spontaneous and ADP-induced platelet ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... Aim. To study the features of the state of hemostasis and platelet enzymes activity ..." | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... antiplatelet effect was evaluated by spontaneous and ADP-induced platelet aggregation assessment. Platelet ..." | ||
| Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
| M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
| "... ) by platelets and neutrophils in patients with coronary heart disease (CHD) before and after coronary artery ..." | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| "... ,3 y.o. in average). Platelet aggregation was assessed by the Born’s method. Level of arachidonic ..." | ||
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Освещены вопросы, касающиеся применения ацетилсалициловой кислоты (АСК) в первичной и вторичной ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... Aim. To estimate the prevalence of atherothrombotic complications depending on platelet ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... into the 2nd group (G2). Platelet aggregation was evaluated by Born's method (inducers of platelet ..." | ||
| Vol 19, No 6 (2023) | Platelet phenotypes and practical aspects of platelet function testing in cardiology | Abstract similar documents |
| Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. A. Boldyreva, D. P. Lazutova, I. A. Meray, M. A. Panteleev | ||
| "... The assessment of platelet dysfunction is usually used by hematologists to diagnose inherited ..." | ||
| Vol 11, No 1 (2015) | EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE | Abstract similar documents |
| K. B. Mirzaev, D. A. Andreev, D. A. Sychev | ||
| "... Evaluation of platelet function with subsequent modification of antiplatelet therapy regimen ..." | ||
| Vol 4, No 2 (2008) | BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL | Abstract similar documents |
| A. N. Zakirova, F. S. Zarudij, B. N. Garifullin | ||
| "... Approaches evolution to studying of beta-blockers influence on platelet aggregation is reviewed ..." | ||
| Vol 10, No 6 (2014) | THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY | Abstract similar documents |
| D. A. Andreev | ||
| "... Council on the significance of testing of platelet functional activity in the prevention of cardiovascular ..." | ||
| Vol 2, No 3 (2006) | CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES | Abstract similar documents |
| P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian | ||
| "... results into platelets activation and thrombus formation. Aspirin - one of the most widely used ..." | ||
| Vol 9, No 3 (2013) | TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN | Abstract similar documents |
| A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin | ||
| Vol 12, No 4 (2016) | High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova | ||
| "... Aim. To study the prevalence of high residual platelet reactivity (HRPR) during the dual ..." | ||
| Vol 7, No 1 (2011) | THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY | Abstract similar documents |
| V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev | ||
| "... was estimated by effects on ADP-induced platelet aggregation initially and after 2 weeks of treatment with each ..." | ||
| Vol 9, No 6 (2013) | ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? | Abstract similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein | ||
| "... The review presents recent data on the usage of platelet functional tests in patients with ischemic ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... Aim. To study the association of nucleotide polymorphisms in platelet receptor and cytochrome P450 ..." | ||
| Vol 19, No 3 (2023) | Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski | ||
| "... 1565C), ITGA2 (C807T), eNOS3 (T786C) genes with high residual platelet reactivity (HRPR) to clopidogrel ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... in enteric form at a dose of 100 mg. To determine the sensitivity to ASA platelet aggregation induced ..." | ||
| Vol 17, No 4 (2021) | Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology | Abstract similar documents |
| M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov | ||
| "... clinical examination, a laboratory assessment of platelet function with the usage of Born method ..." | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... Aim. To analyze the literary and own data about clopidogrel influence on platelets during ..." | ||
| Vol 6, No 2 (2010) | EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION | Abstract PDF (Eng) similar documents |
| A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova | ||
| "... Aim. To study influence of beta-blockers carvedilol and metoprolol tartrate on platelet ..." | ||
| Vol 20, No 4 (2024) | Coagulation disorders in myocardial infarction with nonobstructive coronary arteries | Abstract similar documents |
| A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, G. S. Svidelskaya, A. A. Ignatova, E. A. Ponomarenko, A. A. Martyanov, A. A. Tarakanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova, Z. D. Kobalava | ||
| "... Aim. To investigate the state of the platelet and plasma components of hemostasis in patients ..." | ||
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... 6133 polymorphism is not associated with increased platelet aggregation activity after CABG and does ..." | ||
| Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
| "... syndrome (ACS) and having poorly reduced platelet aggregation (proven by optical aggregometry) in response ..." | ||
| Vol 8, No 4 (2012) | RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS | similar documents |
| S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz | ||
| "... Prevention Evaluation), были: 1) проверка гипотезы о том, что рамиприл улучшает способность тромбоцитов ..." | ||
| Vol 9, No 1 (2013) | POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova | ||
| "... Aim. To evaluate the functional activity of platelets by the optical standard aggregatometry ..." | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... combination on the level of soluble platelet-endothelial cell adhesion molecule of the first type (sPECAM-1 ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... after acute coronary syndrome (ACS) is characterized by high level of platelet reactivity, which ..." | ||
| Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
| Vol 4, No 3 (2008) | COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME | Abstract similar documents |
| E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky | ||
| "... metabolism, platelet aggregation in patients with arterial hypertension (HT) and metabolic syndrome (MS ..." | ||
| Vol 7, No 5 (2011) | HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY | similar documents |
| G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio | ||
| "... стандартной дозами клопидогрела на агрегацию тромбоцитов, воспаление и функцию эндотелия у больных, перенесших ..." | ||
| Vol 2, No 2 (2006) | COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova | ||
| "... resistance, endothelium function, markers of inflammation, and platelet activity in patients with metabolic ..." | ||
| Vol 8, No 4 (2012) | COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS» | similar documents |
| D. V. Nebieridze | ||
| Vol 12, No 5 (2016) | Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention | Abstract similar documents |
| E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva | ||
| "... on-treatment platelet reactivity (according to VerifyNow®), PAI-1 and vWF presenting activity may be useful ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... , platelet aggregation in response to arachidonic acid, the concentration of salicylic acid and the level ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... of cardiovascular complications and activity of platelet aggregation, to assess safety of dual antiplatelet therapy ..." | ||
| Vol 16, No 6 (2020) | Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice? | Abstract similar documents |
| T. M. Uskach, A. S. Tereshchenko | ||
| "... . The new generation of inhibitors of P2Y12 platelet receptors (prasugrel and ticagrelor) provide more ..." | ||
| Vol 13, No 6 (2017) | THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL | Abstract similar documents |
| I. V. Gribkova, M. V. Davydovskaya | ||
| "... (PDI) serves an essential role in the processes of thrombus formation. PDI is secreted by platelets ..." | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... and safety of prolonged use of a combination of acetylsalicylic acid and blocker P2Y12 platelet receptor ..." | ||
| Vol 3, No 3 (2007) | RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov | ||
| "... , and no recommendations for their practical use. It is necessary to work out unified procedure to assess platelet function ..." | ||
| Vol 15, No 2 (2019) | The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention | Abstract similar documents |
| A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov | ||
| "... and platelet P2Y12 receptor inhibitors. One of the first drugs from the group of P2Y12 receptor inhibitors ..." | ||
| Vol 12, No 5 (2016) | The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin | Abstract similar documents |
| I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich | ||
| "... , at the same time the incidence of other TEC was significantly higher in the warfarin group (0 vs 8%, p=0.011 ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... of acetylsalicylic acid (100 mg/day) and ticagrelor 90 mg twice a day. ADP-induced platelet aggregation (1.25 and 2 ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| "... Освещается опыт клинического применения ацетилсалициловой кислоты (АСК) с момента ее синтеза в ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... Рассматривают аспекты применения ацетилсалициловой кислоты (АСК) в кардиологической практике ..." | ||
| Vol 6, No 4 (2010) | CLOPIDOGREL PHARMACOGENETICS | Abstract similar documents |
| A. N. Meshkov | ||
| "... Platelets play an important role in the pathogenesis of atherosclerosis. They are involved ..." | ||
| Vol 11, No 4 (2015) | INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION | Abstract PDF (Eng) similar documents |
| K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev | ||
| "... of CYP3A4 isoenzyme activity and CYP2C19 polymorphisms on platelet aggregation. Material and methods ..." | ||
| Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
| "... protein and decreased platelet count were independently associated with mortality, hypertension having ..." | ||
| Vol 14, No 1 (2018) | NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev | ||
| "... allelic variants were detected by the method of real-time polymerase chain reaction. Platelet functional ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Представлен обзор современных представлений о роли ацетилсалициловой кислоты (АСК) в первичной ..." | ||
| Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
| I. V. Zhirov | ||
| "... (АСК), потенциально связанные с возможностью расширения показаний к ее назначению, в частности, с целью ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... ацетилсалициловой кислоты (АСК) в первичной и вторичной профилактике атеротромбоза. Продолжаются исследования ..." | ||
| Vol 5, No 4 (2009) | GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY | Abstract similar documents |
| A. L. Komarov | ||
| "... , ограничивающим использование ацетилсалициловой кислоты (АСК) у больных атеротромбозом. На сегодняшний день самым ..." | ||
| Vol 14, No 5 (2018) | Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case | Abstract similar documents |
| M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov | ||
| "... by laboratorial VerifyNow P2Y12 Assay test system as a low percentage of inhibition of ADP-induced platelet ..." | ||
| Vol 2, No 3 (2006) | NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION | Abstract similar documents |
| A. I. Martinov, V. L. Chomenko | ||
| "... in variability of heart rhythm. Omega-3 PUFAs cause the reduction in platelet activity and vasoactive mediator ..." | ||
| Vol 18, No 2 (2022) | Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... the relationships with the activation of the hypothalamic-pituitary-adrenal, autonomic nervous system, platelet ..." | ||
| Vol 4, No 5 (2008) | CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| D. A. Poddubnyy, A. P. Rebrov | ||
| "... factors were assessed: C-reactive protein level (CRP), fibrinogen level, platelet count, antithrombin III ..." | ||
| Vol 14, No 2 (2018) | New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion | Abstract similar documents |
| A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko | ||
| "... option of which until recently was an additional treatment with P2Y12 platelet receptors blockers ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... (АСК) в кардиологической практике. Особое внимание уделяется дженерическим препаратам АСК, применение ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi | ||
| "... ацетилсалициловой кислотой (АСК), клопидогрелом и комбинированной антиагрегантной терапии (АСК + клопидогрел ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... of acute cardiovascular events during smoking include the activation of inflammation, platelet aggregation ..." | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... , reduce reperfusion complications, reduce the level of thromboxane and platelet aggregation, and improve ..." | ||
| Vol 2, No 3 (2006) | COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS | Abstract similar documents |
| O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova | ||
| "... platelet aggregation and adhesive property of neutrophils were also estimated. A number of leucocytes ..." | ||
| Vol 15, No 6 (2019) | Coronary Heart Disease in HIV-Infected Patients | Abstract similar documents |
| M. A. Arzhakova, T. A. Shekhovtsova, D. V. Duplyakov | ||
| "... of CD4 cells, a change in the number and function of platelets. The question of the effect ..." | ||
| Vol 10, No 3 (2014) | THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS | Abstract similar documents |
| E. A. Shelest, A. E. Shuganov, L. I. Patrushev, I. N. Bokarev | ||
| "... of intravascular microcoagulation was measured: platelet factor 4 (PF4) by ELISA, D-dimer by ELISA, XIIa-dependent ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... ) enhances platelet hyperreactivity and thrombosis risk and predicts major adverse cardiovascular events ..." | ||
| Vol 12, No 6 (2016) | THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| E. A. Smirnova, S. S. Yakushin | ||
| "... alternative to UFH in combination with GP IIb/IIIa platelet receptor blockers in case of invasive treatment ..." | ||
| Vol 7, No 4 (2011) | PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko | ||
| "... (factor V Leiden G1691A, prothrombin G20210A, ß-fibrinogen 455G> A), platelet GPIIIa receptor (C1565T ..." | ||
| Vol 18, No 1 (2022) | The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" | Abstract similar documents |
| M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok | ||
| "... кислотой (АСК) у пациентов со стабильной ишемической болезнью сердца (ИБС) и высоким риском тромботических ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... позволяет прийти к заключению, что риск, связанный с применением ацетилсалициловой кислоты (АСК) у пациентов ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... , использование низких доз ацетилсалициловой кислоты (АСК), рутинное назначение препаратов из группы ингибиторов ..." | ||
| Vol 20, No 2 (2024) | Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry | Abstract similar documents |
| V. S. Arakelyan, A. D. Erlikh, N. Sh. Amirov, E. Dubar, K. Vogtlaender, S. Debus | ||
| "... терапию ривароксабаном 2,5 мг 2 р/сут. в сочетании с ацетилсалициловой кислотой (АСК) в низкой дозе. В ..." | ||
| Vol 7, No 5 (2011) | THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman | ||
| "... проводили комплексную терапию (ацетилсалициловая кислота (АСК), бета-адреноблокаторы (БАБ), ингибиторы АПФ ..." | ||
| Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
| G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
| "... ://dx.doi.org/10.1016/j.jacc.2012.10.011 ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..." | ||
| Vol 21, No 1 (2025) | Cytokine profile of surgical patients with infective endocarditis | Abstract similar documents |
| E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava | ||
| "... .0001-0.0026], p < 0.05) and IL-6 (Ме [IQR] 0.0034 [0.0007-0.0167] vs. 0.0005 [0.0004-0.0038], p < 0 ..." | ||
| Vol 11, No 2 (2015) | CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE | Abstract similar documents |
| K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva | ||
| "... рецепторов тромбоцитов – эптифибатид. ..." | ||
| Vol 12, No 5 (2016) | Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis | Abstract similar documents |
| M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov | ||
| "... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..." | ||
| Vol 6, No 3 (2010) | EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS | Abstract similar documents |
| S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva | ||
| "... under 1 month administration of ubichinon compositum (0,11 mg/100g of body weight). Results ..." | ||
| Vol 1, No 2 (2005) | INFLUENCE OF MENOPAUSE ON BLOOD PRESSURE DIPPING IN WOMEN WITH METABOLIC SYNDROME: A CASE-CONTROL STUDY | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... .7% [7.9-14.8] in premenopausal women, p=0,011). Conclusion. Postmenopause associates with insufficient ..." | ||
| Vol 14, No 5 (2018) | Clinical Case: Tuberculous Myopericarditis in the Cardiology Practice | Abstract similar documents |
| A. I. Skripka, A. V. Buchneva, V. V. Vankhin, N. V. Lisyanskaya, V. V. Babyre, P. V. Senchikhin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... before the patient’s hospitalization. In lab tests anemia, leucopenia, increase level of platelets ..." | ||
| Vol 16, No 5 (2020) | Clinical Case of Complicated Thrombophilia in a Patient with Ulcerative Colitis | Abstract similar documents |
| S. A. Boldueva, I. V. Yarmosh, A. N. Dolinova, Z. G. Kaloeva, M. Yu. Serkova, V. M. Avramova | ||
| "... of mutations in the genes of factor V Leiden, fibrinogen, platelet receptor for collagen, plasminogen activator ..." | ||
| Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract similar documents |
| O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
| "... — 22,2% (4/18) и средства, влияющие на агрегацию тромбоцитов —11,1% (2/18). Заключение. При проведении ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND | Abstract similar documents |
| V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov | ||
| "... .3±0.8 (p=0.011) in the Group 1 and from 8.5±0.4 to 9.7±0.8 (p=0.083) in the Group 2. Increase ..." | ||
| Vol 16, No 1 (2020) | Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya | ||
| "... (AUC) in the model without EAT thickness constituted 0.708 (p=0.009), and increased up to 0.879 (p=0.011 ..." | ||
| Vol 14, No 2 (2018) | IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE | Abstract similar documents |
| M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko | ||
| "... .3-93.1] mL/min/1.73m2 at discharge (p= 0.011), greatly decreased serum creatinine from 1.17 [0.90-1 ..." | ||
| Vol 12, No 6 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 12, No 1 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... in 26 (83.9%) of 31 patients receiving DOAC and in 19 (51.4%) of 37 patients receiving warfarin (p=0.011 ..." | ||
| Vol 20, No 6 (2024) | Сardiac interoception and its link with psychological characteristics in patients with symptomatic and asymptomatic premature ventricular contractions | Abstract similar documents |
| A. S. Limonova, I. A. Minenko, A. A. Sukmanova, K. V. Davtyan, A. I. Ershova, O. M. Drapkina | ||
| "... levels of personal (p<0.001) and situational (p=0.011) anxiety compared to controls (p<0.001). The total ..." | ||
| Vol 12, No 2 (2016) | CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin | ||
| "... level of MMP-3 (9.31±3.63 ng/ml) versus patients without hypertension (5.02±3.66 ng/ml), р=0.011 ..." | ||
| Vol 6, No 6 (2010) | HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY | Abstract similar documents |
| V. V. Mazur, A. M. Kalinkin, E. S. Mazur | ||
| "... patients at I (5.40±0.11 cm) and IIA (5.80±0.26 cm) CHF stages did not differ from healthy volunteers ..." | ||
| Vol 16, No 4 (2020) | Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation | Abstract similar documents |
| L. I. Folomeeva, E. V. Filippov | ||
| "... ; upper-lower: 6.15±0.03 and 5.96±0.10 cm; medial-lateral: 4.15±0.11 and 3.87±0.09 cm, respectively ..." | ||
| Vol 16, No 4 (2020) | Prevalence and Characteristics of Blood Pressure Phenotypes in Patients with Hypertension and Chronic Respiratory Diseases (Study of Ambulatory Practice Data of a Cardiologist) | Abstract similar documents |
| A. S. Kurekhyan, M. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, M. M. Loukianov | ||
| "... .7%; 25.5% vs 37.1%, respectively, p 148 mm Hg (b=2.733, p=0.040), LAD (b=1.015, p=0.011), serum total ..." | ||
| Vol 15, No 3 (2019) | Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension | Abstract similar documents |
| A. I. Kochetkov, E. V. Borisova, O. D. Ostroumova, M. V. Lopukhina, G. V. Piksina | ||
| "... thickness (from 1.36±0.19 to 1.28±0.18 cm), LV posterior wall thickness (from 1.08±0.09 to 0.97±0.11 cm ..." | ||
| 1 - 100 of 112 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
